|1.||Counsell, Raymond E: 1 article (04/2006)|
|2.||Skinner, R W Scott: 1 article (04/2006)|
|3.||Rampy, Mark A: 1 article (04/2006)|
|4.||Pinchuk, Anatoly N: 1 article (04/2006)|
|5.||Weichert, Jamey P: 1 article (04/2006)|
|6.||Gross, Milton D: 1 article (04/2006)|
|7.||Longino, Marc A: 1 article (04/2006)|
09/01/1996 - "Moreover, preliminary pharmacokinetic studies with NM-324 are being conducted in cancer patients. "
09/01/1996 - "Lipid extraction of the tumors and major organs in both animal models showed the sole presence of unchanged NM-324. "
10/01/1992 - "In addition, NM-324 showed excellent tumor localization in athymic mice bearing subcutaneous human tumors."
04/06/2006 - "A direct comparison between NM-404 and its predecessor, NM-324, in human PC-3 tumor bearing immune-compromised mice revealed a dramatic enhancement in both tumor uptake and total body elimination of NM-404 relative to NM-324. "
10/01/1992 - "However, the tumor avidity of NM-324 was far superior to NM-326. "
|2.||Breast Neoplasms (Breast Cancer)
|1.||18-(4-iodophenyl)octadecylphosphocholine (NM 404)